Among the prementioned hematologic abnormalities, high D-dimer level, prolonged prothrombin time and low platelet count reflect hypercoagulable state in COVID-19 patients that may finally progress to overt disseminated intravascular coagulation [28]. This evidence concerns the gene F2 and COVID-19.